Vyome Biosciences, a clinical-stage specialty biopharmaceutical company developing medicines for treating skin diseases caused by resistant microbes, has received $14 million (approx INR 93 crore) Series-C funding. The round was led by Perceptive Advisors, a New York based life sciences fund and, Romulus Capital, a Boston-based VC firm, along with participation from existing investors including Kalaari Capital, Sabre Partners and Aarin Capital. The funding will be utilized to advance the clinical development of lead product and continue to develop other proprietary products in the pre-clinical stage.
Recruitment firm Kelly Services India and its joint venture partner for Asia Pacific, Temp Holdings, have launched a venture capital fund for startups focused on human resources. The Temp Innovation Fund has set aside Rs 67 crore to invest in disruptive startups engaged in staffing and recruitment services in the country.
Accel India, which is based in Bengaluru, is expected to raise $400-500 million (Rs 2,700-3,300 crore) for its fifth fund. It will formally begin the process by October although it has initiated talks with the Limited Partners who could invest in the fund
Online beauty retailer Nykaa is in talks to raise INR 80 crore by end of this year to push growth as it aims to double sales to Rs 720 crore by 2017-18. The company is looking at diluting 10 per cent equity and expect to close the funding by December this year.
Ruchir Modi’s wellness startup Puro Wellness has raised INR 250 crore from Torrent — the holding company of Gujarat-based conglomerate Torrent Group — in its pre-revenue stage. Torrent has taken a significant stake in Puro Wellness, which aims to develop nutritional supplements that are meal replacements for salt, sugar, spice, rice and other products.